Drug profile · INN
prilocaine hydrochloride
PRILOCAINE HYDROCHLORIDE
prilocaine hydrochloride (PRILOCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
Drug details — prilocaine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
prilocaine hydrochloride (PRILOCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prilocaine hydrochloride?
prilocaine hydrochloride (PRILOCAINE HYDROCHLORIDE) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for prilocaine hydrochloride?
PRILOCAINE HYDROCHLORIDE is a marketed brand name for prilocaine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prilocaine hydrochloride?
prilocaine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.